DK1587500T3 - Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering - Google Patents

Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering

Info

Publication number
DK1587500T3
DK1587500T3 DK03799644.4T DK03799644T DK1587500T3 DK 1587500 T3 DK1587500 T3 DK 1587500T3 DK 03799644 T DK03799644 T DK 03799644T DK 1587500 T3 DK1587500 T3 DK 1587500T3
Authority
DK
Denmark
Prior art keywords
compounds
active substance
oral dosage
taste masking
substance requiring
Prior art date
Application number
DK03799644.4T
Other languages
Danish (da)
English (en)
Inventor
Isabelle Chacornac
Patricia Probeck
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1587500T3 publication Critical patent/DK1587500T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03799644.4T 2002-12-23 2003-12-19 Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering DK1587500T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216521A FR2848855B1 (fr) 2002-12-23 2002-12-23 Compositions pour administration orale de principes actifs necessitant un masquage du gout
PCT/FR2003/003813 WO2004058137A2 (fr) 2002-12-23 2003-12-19 Compositions pour administration orale de principes actifs necessitant un masquage du gout

Publications (1)

Publication Number Publication Date
DK1587500T3 true DK1587500T3 (da) 2014-06-23

Family

ID=32406402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03799644.4T DK1587500T3 (da) 2002-12-23 2003-12-19 Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering

Country Status (14)

Country Link
EP (1) EP1587500B1 (el)
JP (1) JP4676763B2 (el)
AU (1) AU2003299360B2 (el)
BR (1) BR0317654A (el)
CA (1) CA2510373C (el)
CY (1) CY1115401T1 (el)
DK (1) DK1587500T3 (el)
ES (1) ES2470371T3 (el)
FR (1) FR2848855B1 (el)
IL (1) IL169343A (el)
MX (1) MXPA05005640A (el)
PT (1) PT1587500E (el)
SI (1) SI1587500T1 (el)
WO (1) WO2004058137A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1034065C2 (nl) 2007-06-29 2008-12-30 Friesland Brands Bv Bereiding van deeltjes.
FR2959130A1 (fr) 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
FR2968995B1 (fr) 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
FR3000400B1 (fr) 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
TR201809617T4 (tr) * 2013-12-04 2018-07-23 Hovione Scientia Ltd Tat maskeleme formülasyonları içeren kontrast ortamlar.
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
JP3155028B2 (ja) * 1991-06-10 2001-04-09 大川原化工機株式会社 噴霧乾燥造粒装置
JPH05309314A (ja) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd コーティング方法
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
CN100379407C (zh) * 1997-12-19 2008-04-09 史密丝克莱恩比彻姆公司 生产咀嚼分散片的方法
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
CN1343128B (zh) * 1999-03-17 2010-04-21 第一制药株式会社 药物组合物

Also Published As

Publication number Publication date
WO2004058137A2 (fr) 2004-07-15
EP1587500A2 (fr) 2005-10-26
IL169343A0 (en) 2007-07-04
JP4676763B2 (ja) 2011-04-27
WO2004058137A3 (fr) 2005-04-14
FR2848855B1 (fr) 2005-02-11
JP2006515592A (ja) 2006-06-01
CA2510373A1 (fr) 2004-07-15
CA2510373C (fr) 2014-09-30
MXPA05005640A (es) 2005-07-27
AU2003299360B2 (en) 2009-10-29
PT1587500E (pt) 2014-06-24
EP1587500B1 (fr) 2014-03-12
ES2470371T3 (es) 2014-06-23
CY1115401T1 (el) 2017-01-04
SI1587500T1 (sl) 2014-07-31
IL169343A (en) 2011-06-30
BR0317654A (pt) 2005-12-20
AU2003299360A1 (en) 2004-07-22
FR2848855A1 (fr) 2004-06-25

Similar Documents

Publication Publication Date Title
CY2016042I2 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DK1656347T3 (da) Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1353668T3 (da) Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
IS2935B (is) Misnotkunarvarið lyfjaform til skömmtunar um húð
DK1539157T3 (da) Fremgangsmåde til hæmning af choroidal neovaskularisering
HK1085962A1 (en) Method for the production of powdered active substance formulations by means of compressible fluids
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
DK1701698T3 (da) Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779
DK1608362T3 (da) Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
IS7481A (is) Epóthílon til gjafar um munn
DK1501806T3 (da) Præparater til topisk applikation af antiandrogent virksomme substanser
NO20044722L (no) Hoy dose av ibandronat formulering
DK1516540T3 (da) Anvendelse af vitamin D-forbindelser
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1587500T3 (da) Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering
DK1624869T3 (da) Doseringsform indeholdende pantoprazol som aktiv bestanddel
IS7092A (is) Einfaldur skammtur af asíþrómýsíni til meðhöndlunar á sýkingum í öndunarvegi
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1474114T3 (da) Oral doseringsform til reguleret frigivelse af et lægemiddel
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater